Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06242860 · ClinicalTrials.gov registry record · NA
Clinical Study Using Eye Lipid Mobilizer (ELM) With Heat and Vibration To Treat Evaporative Dry Eye Disease
A NA study of Meibomian Gland Dysfunction and Evaporative Dry Eye Disease, sponsored by Eyedetec Medical.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT06242860 is a NA study of Meibomian Gland Dysfunction and Evaporative Dry Eye Disease that has completed, run by Eyedetec Medical. The registered enrollment target is 31 participants, below the 99-participant average among 8 other Meibomian Gland Dysfunction trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06242860, a NA study of Meibomian Gland Dysfunction and Evaporative Dry Eye Disease, has completed, sponsored by Eyedetec Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate the Eye Lipid Mobilizer (ELM) for the treatment of evaporative dry eye disease associated with meibomian gland dysfunction. The main questions aim to confirm that 1) the ELM can meet its intended use by validated patient reporting outcomes and 2) to confirm that the ELM device can be used safely by different users within a clinical environment as determined by review of any adverse events related to the use of the device.
Conditions Studied
Interventions
- DEVICE ELM
Study Locations (1)
California
- EYEcenter Optometric - Citrus Heights
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2022-02-08 |
| Est. Completion | 2022-03-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06242860
The ClinicalTrials.gov registry entry for NCT06242860 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 99-participant average among 8 other Meibomian Gland Dysfunction trials with a reported enrollment target (69% lower). The listed sponsor is Eyedetec Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Meibomian Gland Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which ELM is the first listed.
NCT06242860 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06242860 about?
NCT06242860 is a clinical study titled "Clinical Study Using Eye Lipid Mobilizer (ELM) With Heat and Vibration To Treat Evaporative Dry Eye Disease". The goal of this clinical trial is to evaluate the Eye Lipid Mobilizer (ELM) for the treatment of evaporative dry eye disease associated with meibomian gland dysfunction. The main questions aim to confirm that 1) the ELM can meet its intended use by validated patient reporting outcomes and 2) to con...
What is the current status of trial NCT06242860?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2022-02-08. Estimated completion is 2022-03-14.
What conditions does trial NCT06242860 study?
This clinical trial studies the following conditions: Meibomian Gland Dysfunction, Evaporative Dry Eye Disease.
What interventions are being tested in trial NCT06242860?
The interventions under investigation include: ELM (DEVICE).
Who is sponsoring clinical trial NCT06242860?
This trial is sponsored by Eyedetec Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06242860 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Meibomian Gland Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Meibomian Gland Dysfunction Management
ACTIVE NOT RECRUITING · NA
-
Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD
ACTIVE NOT RECRUITING · NA
-
Comparison Between iLux™ and LipiFlow® in the Treatment of Meibomian Gland Dysfunction
COMPLETED · NA
-
The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction
COMPLETED · NA
-
Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study
COMPLETED · NA
-
Tear Film Innovations iLux Safety Study
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.